🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Status
Terminated
Location
GSK Investigational Site
Start Date
2009-04-01
Trial ID
NCT00871741
Treatments Being Tested
The purpose of this study is to evaluate safety and immunogenicity of Pedia...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00343421
Treatments Being Tested
The aim of the study was to investigate the immunogenicity and safety of CY...
Status
Terminated
Location
Multiple Locations
Start Date
2016-12-19
Trial ID
NCT02992418
The purpose of the study is to provide immunogenicity and safety data of th...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00401531
This study is evaluating the safety and immunogenicity of Hib-MenCY-TT vacc...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04-11
Trial ID
NCT00134719
Treatments Being Tested
The purpose of this study is to assess the immunogenicity, safety and react...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01-10
Trial ID
NCT01767376
Treatments Being Tested
It is well recognized that older adults can contract pertussis, suffer its ...
Status
Completed
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT00457249
The goal of this observational study is to learn about vaccine immunity in ...
Status
Recruiting
Location
University Hospital Bern
Start Date
2023-11-14
Trial ID
NCT06333275
This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-08-13
Trial ID
NCT00970307
Treatments Being Tested
Objectives: * To present the rates of adverse reactions after a dose of DA...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT00802867
Treatments Being Tested